Godavari Drugs Limited (GODAVARI.BO)
INR 89.01
(-3.48%)
INR 89.01
(-3.48%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 957.86 Million INR | 4.34% |
| 2022 | 918.01 Million INR | 27.89% |
| 2021 | 717.79 Million INR | 7.53% |
| 2020 | 667.53 Million INR | 4.86% |
| 2019 | 636.58 Million INR | 14.74% |
| 2018 | 554.8 Million INR | 20.68% |
| 2017 | 459.74 Million INR | 16.45% |
| 2016 | 394.8 Million INR | 9.26% |
| 2015 | 361.34 Million INR | 66.66% |
| 2014 | 216.81 Million INR | 277.69% |
| 2013 | 57.4 Million INR | -17.92% |
| 2012 | 69.94 Million INR | 0.0% |
| 2010 | 49.23 Million INR | 34.99% |
| 2009 | 36.46 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -389.66 Million INR | -140.68% |
| 2023 Q2 | 920.85 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 957.86 Million INR | 0.0% |
| 2023 FY | 957.86 Million INR | 4.34% |
| 2022 FY | 918.01 Million INR | 27.89% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 923.84 Million INR | 0.0% |
| 2022 Q4 | 918.01 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 793.83 Million INR | 0.0% |
| 2021 FY | 717.79 Million INR | 7.53% |
| 2021 Q4 | 717.79 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 667.53 Million INR | 4.86% |
| 2020 Q4 | 667.53 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 641.23 Million INR | 0.0% |
| 2019 Q2 | 556.54 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 636.58 Million INR | 14.74% |
| 2019 Q4 | 636.58 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 554.8 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 511.15 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 554.8 Million INR | 20.68% |
| 2017 Q4 | 459.74 Million INR | 0.0% |
| 2017 Q2 | 443.64 Million INR | 2.47% |
| 2017 FY | 459.74 Million INR | 16.45% |
| 2017 Q1 | 432.93 Million INR | 9.66% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 417.85 Million INR | 0.0% |
| 2016 FY | 394.8 Million INR | 9.26% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 394.8 Million INR | 0.0% |
| 2015 Q2 | 362.11 Million INR | 0.0% |
| 2015 Q4 | 361.34 Million INR | 0.0% |
| 2015 FY | 361.34 Million INR | 66.66% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 FY | 216.81 Million INR | 277.69% |
| 2014 Q4 | 216.81 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 177.49 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q4 | 57.4 Million INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 57.4 Million INR | -17.92% |
| 2012 Q4 | 69.94 Million INR | 0.0% |
| 2012 FY | 69.94 Million INR | 0.0% |
| 2010 Q4 | 49.23 Million INR | 0.0% |
| 2010 FY | 49.23 Million INR | 34.99% |
| 2009 FY | 36.46 Million INR | 0.0% |
| 2009 Q4 | 36.46 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -3626.943% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 36.167% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 3.863% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -4463.43% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -1685.494% |
| Sunil Healthcare Limited | 902.83 Million INR | -6.096% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -44912.406% |
| MedPlus Health Services Limited | 14.27 Billion INR | 93.29% |
| Zenith Healthcare Limited | 24.03 Million INR | -3885.288% |
| Patidar Buildcon Limited | 25.57 Million INR | -3645.753% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -517.718% |
| Roopa Industries Limited | 493.08 Million INR | -94.259% |
| Smruthi Organics Limited | 485.72 Million INR | -97.205% |
| Trident Lifeline Limited | 331.26 Million INR | -189.156% |
| Bacil Pharma Limited | 1.12 Million INR | -84741.807% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -359.537% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -492.466% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 4.627% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -710.218% |
| PANJON LTD. | 25.38 Million INR | -3673.644% |
| Tyche Industries Limited | 101.64 Million INR | -842.399% |
| Trimurthi Limited | 101.36 Thousand INR | -944911.839% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -6294.713% |
| Anuh Pharma Limited | 1.54 Billion INR | 37.987% |
| Crestchem Limited | 23.94 Million INR | -3899.933% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -7045.573% |
| Zenlabs Ethica Limited | 301.35 Million INR | -217.853% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -228.625% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 42.353% |
| Parmax Pharma Limited | 117.56 Million INR | -714.734% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 48.537% |
| Deccan Health Care Limited | 111.33 Million INR | -760.336% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -374.251% |
| Norris Medicines Limited | 278.17 Million INR | -244.341% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 44.121% |
| Veerhealth Care Limited | 62.78 Million INR | -1425.747% |
| Makers Laboratories Limited | 569.18 Million INR | -68.288% |
| Lactose (India) Limited | 536.39 Million INR | -78.574% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | -14.97% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 15.301% |
| Mercury Laboratories Limited | 171.18 Million INR | -459.536% |
| Gennex Laboratories Limited | 535.21 Million INR | -78.969% |
| PRAVEG LIMITED | 767.53 Million INR | -24.797% |
| Denis Chem Lab Limited | 289.82 Million INR | -230.501% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 44.189% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -375.15% |
| Colinz Laboratories Limited | 24.1 Million INR | -3873.715% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -320255.853% |
| Zenotech Laboratories Limited | 156.64 Million INR | -511.475% |
| Panchsheel Organics Limited | 340.2 Million INR | -181.557% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -96.136% |
| Vivanza Biosciences Limited | 148.63 Million INR | -544.458% |
| Phaarmasia Limited | 211.49 Million INR | -352.901% |
| Bharat Parenterals Limited | 2.65 Billion INR | 63.942% |
| Medi-Caps Limited | 63.01 Million INR | -1420.033% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -713.645% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -385.307% |
| BDH Industries Limited | 312.53 Million INR | -206.482% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -446.829% |
| Coral Laboratories Limited | 281.83 Million INR | -239.862% |
| Concord Drugs Limited | 249.88 Million INR | -283.32% |
| Beryl Drugs Limited | 85.63 Million INR | -1018.53% |
| Evoq Remedies Limited | 116.23 Million INR | -724.097% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -501.658% |
| Transchem Limited | 6.72 Million INR | -14153.929% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -10696.483% |
| Parnax Lab Limited | 1.17 Billion INR | 18.181% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -2182.15% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 9.435% |
| Cian Healthcare Limited | 1.03 Billion INR | 7.395% |
| Trinity League India Limited | 876 Thousand INR | -109245.205% |
| Syschem (India) Limited | 1.07 Billion INR | 10.54% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 53.116% |
| Natural Capsules Limited | 1.47 Billion INR | 35.157% |
| Auro Laboratories Limited | 433.09 Million INR | -121.166% |